Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Jul 16;26(Suppl 4):5–9. doi: 10.1002/clc.4960261603

The evolving role of diltiazem hydrochloride in cardiovascular management

William H Frishman 1,✉
PMCID: PMC6653899

Full Text

The Full Text of this article is available as a PDF (492.2 KB).

References

  • 1. Pool PE: Anomalies in the dosing of diltiazem. Clin Cardiol 2000; 23: 18–23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Frishman WH, Charlap S, Goldberger J, Kimmel B, Stroh J, Dorsa F, Allen L, Strom J: Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. Am J Cardiol 1985; 56: 41H–46H [DOI] [PubMed] [Google Scholar]
  • 3. Massie BM, Der E, Herman TS, Topolski P, Park GD, Stewart WH: 24‐hour efficacy of once‐daily diltiazem in essential hypertension. Clin Cardiol 1992; 15: 365–368 [DOI] [PubMed] [Google Scholar]
  • 4. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RS, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG: Single‐drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. The Department of Veteran Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328: 914–921 [DOI] [PubMed] [Google Scholar]
  • 5. Pool PE, Massie BM, Venkataraman K, Hirsch A, Samant DR, Seagren SC, Gaw J, Salel AF, Tubau JF: Diltiazem as monotherapy for systemic hypertension: A multicenter, randomized, placebo‐controlled trial. Am J Cardiol 1986; 57: 212–217 [DOI] [PubMed] [Google Scholar]
  • 6. Chugh SK, Digpal K, Hutchison T, McDonald CJ, Miller AJ, Lahiri A: A randomized, double blind comparison of the efficacy and tolerability of once‐daily modified‐release diltiazem capsules with once‐daily amlodipine tablets in patients with stable angina. J Cardiovasc Pharmacol 2001; 38: 356–364 [DOI] [PubMed] [Google Scholar]
  • 7. Klinke WP, Kvill L, Dempsey EE, Grace M: A randomized double‐blind comparison of diltiazem and nifedipine in stable angina. J Am Coll Cardiol 1988; 12: 1562–1567 [DOI] [PubMed] [Google Scholar]
  • 8. Strauss WB, McIntyre KM, Parisi AF, Shapiro W: Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trial. Am J Cardiol 1982; 49: 560–566 [DOI] [PubMed] [Google Scholar]
  • 9. Buckley MM, Grant SM, Goa KL, McTavish D, Sorkin EM: Diltiazem: A reappraisal of its pharmacological properties and therapeutic use. Drugs 1990; 39: 757–806 [DOI] [PubMed] [Google Scholar]
  • 10. Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G: Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 200; 29: 1149–1153 [DOI] [PubMed] [Google Scholar]
  • 11. Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ: Regional and racial differences in response to antihypertensive medication in a randomized, controlled trial of men with hypertension in the United States. Dept. of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 2000; 160: 825–831 [DOI] [PubMed] [Google Scholar]
  • 12. Tarif N, Bakris GL: Preservation of renal function: The spectrum of effects by calcium‐channel blockers. Nephrol Dial Transplant 1997; 12: 2244–2250 [DOI] [PubMed] [Google Scholar]
  • 13. Frishman WH, Sica DA: Calcium‐channel blockers In Cardiovascular Pharmacotherapeutics, 2nd edition (Eds. Frishman WH, Sonnenblick EH, Sica DA.), p. 105–130 New York: McGraw Hill, 2003. [Google Scholar]
  • 14. Palma‐Gamiz JL: High blood pressure and calcium antagonism. Cardiology 1997; 88: 39–46 [DOI] [PubMed] [Google Scholar]
  • 15. Woehler TR, Eff J, Graney W, Eff J, Graney W, Heald D, Ziemniak J, Magner D: Multicenter evaluation of the efficacy and safety of sustained‐release diltiazem hydrochloride for the treatment of hypertension. Clin Ther 1992; 14: 148–157 [PubMed] [Google Scholar]
  • 16. Leenen FH, Fourney A: Comparison of the effects of amlodipine and diltiazem on 24‐hour blood pressure, plasma catecholamines, and left ventricular mass. Am J Cardiol 1996; 78: 203–207 [PubMed] [Google Scholar]
  • 17. Fagan TC: Diltiazem: Its place in the antihypertensive armamentarium. J Cardiovasc Pharmacol 1991; 18 (suppl 9): S26–S31 [PubMed] [Google Scholar]
  • 18. Prida XE, Gelman JS, Feldman RL, Hill JA, Pepine CJ, Scott E: Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm. J Am Coll Cardiol 1987; 9 (2): 412–419 [DOI] [PubMed] [Google Scholar]
  • 19. Frishman W, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J: Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: Effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Circulation 1988; 77 (4): 774–786 [DOI] [PubMed] [Google Scholar]
  • 20. Fodor GJ, Boulet AP, Savard D, Nadeau C, Rakusan K, Chockalingam A, Langer A: The role of diltiazem in treating hypertension and coronary artery disease: New approaches to preventing first events. Can J Cardiol 1997; 13: 495–503 [PubMed] [Google Scholar]
  • 21. Hansson L, Hedner T, Lund‐Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlof B, Karlberg BE: Randomised trial of effects of calcium antagonists compared with diuretics and beta‐blockers on cardiovascular morbidity and mortality in hypertension: The Nordic diltiazem (NORDIL) study. Lancet 2000; 356: 359–365 [DOI] [PubMed] [Google Scholar]
  • 22. Boden WE, Kleiger RE, Gibson R, Reddy BR, Schechtman KB, Schwartz DJ, Capone RJ, Roberts R, the Diltiazem Reinfarction Study Research Group : Favourable long‐term prognosis in patients with non‐Q‐wave acute myocardial infarction not associated with specific electrocardiographic changes. Br Heart J 1989; 61: 396–402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Gibson RS, Boden WE, Théroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, Young PM, Schechtman K, Perryman B, Roberts R, the Diltiazem Reinfarction Study Group : Diltiazem and reinfarction in patients with non‐Q‐wave myocardial infarction. Results of a double‐blind, randomized, multicenter trial. N Engl J Med 1986; 315: 423–429 [DOI] [PubMed] [Google Scholar]
  • 24. Roberts R, Gibson RS, the Diltiazem Reinfarction Study Investigators : Prevention of reinfarction subsequent to non‐Q‐wave infarction. J Cardiovasc Pharmacol 1989; 13 (suppl 1): S36–S46 [DOI] [PubMed] [Google Scholar]
  • 25. Ruddy MC: The INSIGHT and NORDIL trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection? Curr Hypertens Rep 2001; 3: 289–296 [DOI] [PubMed] [Google Scholar]
  • 26. Jollis JG, Simpson RJ Jr, Chowdhury MK, Cascio WE, Crouse JR, Massing MW, Smith SC: Calcium channel blockers and mortality in elderly patients with myocardial infarction. Arch Intern Med 1999; 159: 2341–2348 [DOI] [PubMed] [Google Scholar]
  • 27. Terranova R, Luca S: Treatment of arterial hypertension in the elderly with diltiazem vs. ramipril. Minerva Cardioangiol 2000; 48: 183–196 [PubMed] [Google Scholar]
  • 28. Demarie BK, Bakris GL: Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113: 987–988 [DOI] [PubMed] [Google Scholar]
  • 29. Frishman WH, Zawada ET, Smith LK, Sowers J, Swartz SL, Kirkendall W, Lunn J, McCarron D, Moser M, Schnaper H: Comparison of hydrochlorothiazide and sustained‐release diltiazem for mild‐to‐moderate systemic hypertension. Am J Cardiol 1987; 59: 615–623 [DOI] [PubMed] [Google Scholar]
  • 30. Schulte KL, Meyer‐Sabellek WA, Haertenberger A, Thiede HM, Roecker L, Ditler A, Gotzen R: Antihypertensive and metabolic effects of diltiazem and nifedipine. Hypertension 1986; 8: 859–865 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES